Improving Participation in Pulmonary Rehabilitation Through Peer Support and Storytelling (ImPReSS-COPD)

June 3, 2026 updated by: Baystate Medical Center
Chronic Obstructive Pulmonary Disease (COPD) affects approximately 16 million Americans and is characterized by recurrent exacerbations that lead to 1.5 million Emergency Department visits and 700,000 hospitalizations annually. Pulmonary rehabilitation (PR) is a structured program of exercise and self-management support that has been proven to relieve shortness of breath and increase quality of life when initiated after an exacerbation, but unfortunately, few eligible patients participate. This project will compare the effectiveness of two novel strategies - one involving video narratives of other patients telling their story of how they overcame challenges and completed PR, the other involving telephonic peer coaching with an individual with lived experience - to enhanced usual care, and to each other, at increasing patient participation in PR after an exacerbation.

Study Overview

Detailed Description

Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) lead to roughly 1.5 million ED visits and 700,000 hospitalizations annually. Recovery is slow and accompanied by high levels of acute care utilization and mortality. Pulmonary Rehabilitation (PR) is a structured program of exercise and self-management support that has been shown to relieve dyspnea and improve quality of life. Clinical guidelines recommend PR for patients with stable COPD and after an exacerbation. Unfortunately, even when referred by physicians, research has shown that few patients who might benefit from PR ever begin treatment.

The primary goal of this project is to identify effective strategies for promoting and sustaining participation in PR. Peer Support involves pairing a patient with a trained peer from a similar background, and facing similar health challenges, who has completed PR. There is a growing body of evidence demonstrating the feasibility, acceptability, and effectiveness of telephonic peer support for chronic disease management. Narrative interventions, or 'Storytelling', are novel approaches for changing attitudes and behaviors of patients that involve creating and disseminating videos narrated by individuals with lived experience with the same condition or facing the same treatment. Storytelling interventions have been shown to help individuals achieve better blood pressure control, and storytelling is being studied in a variety of other clinical contexts.

In the R61 Phase, the investigators will recruit and train a cohort of peer coaches in behavior change techniques, and will recruit a diverse group of storytellers, capture their narratives on video, and create a library of 6-8 powerful stories. The investigators will finalize the protocol, trial infrastructure, and pilot the recruitment strategy. During the R33 Phase, the investigators will recruit 305 adults treated for exacerbation of COPD, and randomize them to 1) Enhanced "Usual Care" (eUC); 2) eUC + Storytelling; or 3) eUC + Peer Support. The investigators will evaluate the effectiveness of each strategy compared to eUC, and to each other, at promoting participation in PR at 6 months.

Using a mixed-methods approach, the investigators will evaluate intervention acceptability, sustainability, and cost, from the perspectives of the patients and peer coaches as well as PR program staff and hospital leadership. This information will be uses to refine the strategies and to disseminate an implementation package that will enable other PR programs to adopt these approaches.

Study Type

Interventional

Enrollment (Estimated)

305

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 40 years or older
  • Received treatment for COPD exacerbation in either inpatient or outpatient setting
  • Referred for pulmonary rehabilitation
  • Ability to understand and communicate in English
  • Willingness to participate in calls with peer coach and to view storytelling videos
  • Working phone

Exclusion Criteria:

  • Unwilling to attend PR
  • Not eligible for PR based on spirometry or other clinical contraindications as determined by PR staff
  • Currently enrolled in, or completion of 12 or more sessions of PR in the past
  • Comfort measures only or Hospice care
  • Resident of long-term care facility
  • Unable or unwilling to give informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Enhanced usual care
Enhanced usual care describes a process in which automated surveillance is used to identify individuals experiencing a COPD exacerbation. This is followed by direct outreach - either through in-person visits while a patient is hospitalized, or by mail and telephone in the outpatient setting, to facilitate referral to PR. Subjects randomized to this arm will be given a pamphlet describing the benefits of PR.
Active Comparator: Enhanced usual care + Storytelling
Subjects randomized to the eUC + Storytelling intervention will view the video narrative(s) of one or more individuals with COPD who has overcome similar barriers and has attended a program of PR. Subjects will be shown the first chapter of the story immediately after randomization and will receive email and/or text messages to prompt viewing of subsequent chapters at 2 weeks, 1 month, 2 months, 3 months and 5 months. Emails and text messages will include a link to a REDCap document that contains a set of embedded video clips representing the next chapter in each storyteller's narrative.
Video narratives of an individual with lived experience with COPD and Pulmonary Rehabilitation describing their journey through Pulmonary Rehabilitation
Active Comparator: Enhanced usual care + Peer support
Subjects randomized to the eUC + Peer support intervention will be matched with a peer coach of the same gender, race, and approximate age. For those enrolled during a hospitalization, coaches will be instructed to attempt the initial phone contact prior to the patient's discharge; for patients enrolled after an ED visit or outpatient exacerbation, coaches will be instructed to contact the patients within 72 hours of randomization. Peer coaches will be asked to complete at least one call each week during months 1-2, biweekly calls during months 3-4, and monthly calls during months 5-6. Coaches will be asked to follow a conversation guide, provided during the initial training, to structure phone conversations with their paired patient.
Telephonic Peer Coaching from an individual with lived experience with COPD and Pulmonary Rehabilitation trained in motivational interviewing

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of Pulmonary Rehabilitation (PR) sessions: Completion of ≥6 PR sessions within 6 months of randomization
Time Frame: 6 months
6 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Any attendance (yes/no) at PR within 6 months of randomization.
Time Frame: 6 months
6 months
Total number of PR sessions completed within 6 months of randomization.
Time Frame: 6 months
6 months
Time to first PR session attended
Time Frame: 6 months
6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Modified Medical Research Council (mMRC) dyspnea scale from randomization to 6 months
Time Frame: 6 months
6 months
Change in Clinical COPD Questionnaire (CCQ) from randomization to 6 months
Time Frame: 6 months
6 months
Change in Hospital Anxiety and Depression Scale (HADS) from randomization to 6 months
Time Frame: 6 months
6 months
Activation (Self Efficacy for Managing Chronic Diseases 6)
Time Frame: 6 months
6 months
Change in Medical Outcomes Survey (MOS) Social Support Survey from randomization to 6 months
Time Frame: 6 months
6 months
Change in UCLA Loneliness Scale from randomization to 6 months
Time Frame: 6 months
6 months
Total # of COPD Exacerbations
Time Frame: 6 months
6 months
Total # of ED visits
Time Frame: 6 months
6 months
Total # of Hospitalizations
Time Frame: 6 months
6 months
Change in Modified Medical Research Council (mMRC) dyspnea scale from enrollment to 12 months - For Peer Coach subjects
Time Frame: 12 months
12 months
Change in Clinical COPD Questionnaire (CCQ) from enrollment to 12 months- For Peer Coach subjects
Time Frame: 12 months
12 months
Change in Activation (Self Efficacy for Managing Chronic Diseases 6) from enrollment to 12 months - For Peer Coach subjects
Time Frame: 12 months
12 months
Change in Hospital Anxiety and Depression Scale (HADS) from enrollment to 12 months - For Peer Coach subjects
Time Frame: 12 months
12 months
Change in UCLA Loneliness Scale from enrollment to 12 months - For Peer Coach subjects
Time Frame: 12 months
12 months
Change in Satisfaction with life scale (SWLS) from enrollment to 12 months - For Peer Coach subjects
Time Frame: 12 months
12 months
Breathlessness belief questionnaire
Time Frame: 6-months.
11-item scale to measure activity avoidance due to dyspnea.
6-months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Peter Lindenauer, MD, MSc, Baystate Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 24, 2023

Primary Completion (Estimated)

July 30, 2026

Study Completion (Estimated)

January 31, 2027

Study Registration Dates

First Submitted

May 24, 2022

First Submitted That Met QC Criteria

May 26, 2022

First Posted (Actual)

June 1, 2022

Study Record Updates

Last Update Posted (Actual)

June 5, 2026

Last Update Submitted That Met QC Criteria

June 3, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

We will share deidentified individual participant data upon receipt and approval of research question and analysis plan from a researcher; or for teaching purposes.

IPD Sharing Time Frame

We will share deidentified IPD based on our criteria within 3 months after publication of our study results in scientific journals without any time limit to share thereafter.

IPD Sharing Access Criteria

Access will be based on receipt of research question/s and analysis strategies planned by a researcher. Approval to access the deidentified IDP will be granted to the researcher if deemed relevant by the study PI.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe